 |
Odyssey Therapeutics
Last updated: June 14, 2024
Gary Glick, CEO
USA | Funding: $487M (+)
Website: https://www.odysseytherapeutics.com
Odyssey Therapeutics is a computational immunology company that develops novel therapeutics for patients with autoimmune diseases.
Website: https://www.odysseytherapeutics.com
Odyssey Therapeutics is a computational immunology company that develops novel therapeutics for patients with autoimmune diseases.
